Stock Trading History of Lynch Samuel Eugene

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lynch Samuel Eugene since year 2005. The trader's CIK number is 1362148. At the time of this reporting, Lynch Samuel Eugene is the President and CEO of Biomimetic Therapeutics, Inc. . (stock ticker symbol BMTI). See this page for all insider trading activities at Biomimetic Therapeutics, Inc. .

Stock purchases, sales, and option exercises reported by insider *Lynch Samuel Eugene* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2008-03-28	BMTI	Biomimetic Therapeutics, Inc.	Purchase	5,400	8.93	48,231
2007-02-14	BMTI	Biomimetic Therapeutics, Inc.	Sale	236,239	17.15	4,051,498
2006-05-12	BMTI	Biomimetic Therapeutics, Inc.	Purchase	12,500	8.00	100,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lynch Samuel Eugene (President and CEO of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.